UMDNJ-NJMS Education Clinical Community
NJMS Home Departments Centers and Institutes NJMS Intranet About NJMS Contact Us
 
Home
About
Faculty
Divisions
Centers Institutes
Education
Research
Clinical
Contact Us

 

Search NJMS 
Departments > Medicine > Divisions > Clinical > Prevent tdvax

Tetanus Vaccine

(Following Excerpt from Centers for Disease Control and Prevention for page " MMWR August 08, 1991 / 40(RR10);1-28 ")

Tetanus in the United States is primarily a disease of older adults. Of 99 tetanus patients with complete information reported to CDC during 1987 and 1988, 68% were greater than or equal to 50 years of age, while only six were less than 20 years of age. No cases of neonatal tetanus were reported. Overall, the case-fatality rate was 21% (8). The age distribution of recent cases and the results of serosurveys indicate that many U.S. adults are not protected against tetanus. Serosurveys undertaken since 1977 indicate that 6%-11% of adults 18-39 years of age and 49%-66% of those greater than or equal to 60 years of age may lack protective levels of circulating tetanus antitoxin (4-7). The disease continues to occur almost exclusively among persons who are unvaccinated or inadequately vaccinated or whose vaccination histories are unknown or uncertain (8).

Campus Resources :

For more instant information on this topic please see links below :